ImmuCell Corp Share Price Today: Live Updates & Key Insights

ImmuCell Corp share price today is $6.08, up -1.3%. The stock opened at $6.266 against the previous close of $6.15, with an intraday high of $6.266 and low of $6.185.

ImmuCell Corp Share Price Chart

ImmuCell Corp

us-stock
To Invest in {{usstockname}}
us-stock

ImmuCell Corp Share Price Performance

$6.08 -0.013(-1.3%) ICCC at 23 Mar 2026 01:34 PM Biotechnology
Lowest Today 6.185
Highest Today 6.266
Today’s Open 6.266
Prev. Close 6.15
52 Week High 7.60
52 Week Low 4.52
Day’s Range: Low 6.185 High 6.266
52-Week Range: Low 4.52 High 7.60
1 day return -
1 Week return -4.43
1 month return -8.89
3 month return +0.66
6 month return -3.36
1 year return +19.6
3 year return +19.6
5 year return -46.21
10 year return -

ImmuCell Corp Institutional Holdings

Vanguard Group Inc 3.35

Vanguard Total Stock Mkt Idx Inv 2.00

Renaissance Technologies Corp 1.67

Cresset Asset Management, LLC 1.50

Morgan Stanley - Brokerage Accounts 1.16

Bleichroeder LP 1.12

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Geode Capital Management, LLC 0.80

Steadtrust LLC 0.63

Dimensional Fund Advisors, Inc. 0.60

Dauntless Investment Group, LLC 0.44

Citadel Advisors Llc 0.44

Northern Trust Corp 0.42

Strategic Investment Advisors Inc 0.41

Mesirow Fin Investmt Mgmt Intl Equity 0.40

Shufro Rose & CO LLC 0.39

Fidelity Extended Market Index 0.38

HighTower Advisors, LLC 0.21

DFA US Core Equity 2 I 0.20

iShares Micro-Cap ETF 0.19

BlackRock Inc 0.18

Fidelity Total Market Index 0.15

Essex Financial Services, Inc. 0.12

Fidelity Series Total Market Index 0.10

Spartan Extended Market Index Pool F 0.09

NT Ext Equity Mkt Idx Fd - NL 0.08

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Spartan Total Market Index Pool G 0.05

DFA US Targeted Value I 0.05

HM Payson & Co 0.04

Vanguard Instl Ttl Stck Mkt Idx Tr 0.04

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

DFA US Vector Equity I 0.03

Dimensional US Targeted Value ETF 0.03

DFA US Core Equity Class F 0.03

DFA US Social Core Equity 2 Portfolio 0.02

Bank of America Corp 0.02

Fidelity Nasdaq Composite Index 0.02

UBS Group AG 0.01

ImmuCell Corp Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

ImmuCell Corp Fundamentals

Market Cap 54.73 M

PB Ratio 2.0563

PE Ratio 28.8095

Enterprise Value 65.35 M

Total Assets 42.53 M

Volume 41198

ImmuCell Corp Company Financials

Annual Revenue FY23:16286588 16.3M, FY22:18568000 18.6M, FY21:19243000 19.2M, FY20:15342000 15.3M, FY19:13723000 13.7M

Annual Profit FY23:3603720 3.6M, FY22:7649000 7.6M, FY21:8656000 8.7M, FY20:6863000 6.9M, FY19:6740000 6.7M

Annual Net worth FY23:-6302633 -6.3M, FY22:-2494000 -2.5M, FY21:-78000 -0.1M, FY20:-1022000 -1.0M, FY19:-1296000 -1.3M

Quarterly Revenue Q3/2025:5506122 5.5M, Q2/2025:6444880 6.4M, Q1/2025:8067174 8.1M, Q3/2024:6011573000 6011.6M, Q2/2024:5472890 5.5M

Quarterly Profit Q3/2025:2363098 2.4M, Q2/2025:2817924 2.8M, Q1/2025:3353972 3.4M, Q3/2024:1583554000 1583.6M, Q2/2024:1230486 1.2M

Quarterly Net worth Q3/2025:-139748 -0.1M, Q2/2025:501880 0.5M, Q1/2025:1446983 1.4M, Q3/2024:-701690000 -701.7M, Q2/2024:-1531626 -1.5M

About ImmuCell Corp & investment objective

Company Information ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Organisation Biotechnology

Employees 77

Industry Biotechnology

CEO Mr. P. F. Olivier Te Boekhorst

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ImmuCell Corp FAQs

What is the share price of ImmuCell Corp today?

The current share price of ImmuCell Corp is $6.08.

Can I buy ImmuCell Corp shares in India?

Yes, Indian investors can buy ImmuCell Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy ImmuCell Corp shares in India?

You can easily invest in ImmuCell Corp shares from India by:

Can I buy fractional shares of ImmuCell Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ImmuCell Corp?

ImmuCell Corp has a market cap of $54.73 M.

In which sector does ImmuCell Corp belong?

ImmuCell Corp operates in the Biotechnology sector.

What documents are required to invest in ImmuCell Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of ImmuCell Corp?

The PE ratio of ImmuCell Corp is 28.81 and the PB ratio is 2.06.